COVID-19 vaccination uptake in Ohio: analyzing the difference between metro and non-metro residents.

Publication date: Mar 22, 2025

The COVID-19 pandemic resulted in the rapid development and distribution of vaccines as a critical strategy to control the spread of the virus. This paper explores COVID-19 vaccine uptake in the state of Ohio, with a particular focus on the difference between metro and non-metro residents. Survey data collected as part of the IMPACT-Ohio Project were used for this study. From August 2021 to February 2023, 3,806 individuals who resided in 12 Ohio counties (six metro and six non-metro counties) responded to the survey. Chi-square tests compared the relationships between various demographic, socio-economic and clinical characteristics among metro and non-metro region respondents. Binary logistic regression modeled the probability of receipt of COVID-19 vaccine and compared those Ohioans who lived in metro (RUCC codes 1-3) vs non-metro (RUCC codes 4-9) counties with adjustment of various covariates. Participants residing in metro counties were almost two times more likely to receive the COVID-19 vaccine compared to those living in non-metro counties adjusting for demographic, socioeconomic and clinical characteristics (aOR: 1. 89, 95% CI: 1. 38-2. 58, P 

Open Access PDF

Concepts Keywords
August Adolescent
February Adult
Ohioans Aged
Socioeconomic COVID-19
Vaccines COVID-19 vaccine
COVID-19 Vaccines
COVID-19 Vaccines
Female
Food insecurity
Humans
Male
Middle Aged
Ohio
Prevention
Public health
Rural Population
Rurality
SARS-CoV-2
Socioeconomic Factors
Surveys and Questionnaires
Vaccination
Vaccine acceptance
Vaccine hesitancy
Young Adult

Semantics

Type Source Name
disease MESH COVID-19
pathway REACTOME Reproduction
disease MESH tics
disease MESH education level
drug DRUGBANK Coenzyme M
disease IDO intervention
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH infections
disease MESH Long COVID
disease MESH panic
drug DRUGBANK Trestolone
disease IDO history
drug DRUGBANK Indoleacetic acid
disease MESH confusion
drug DRUGBANK Fenamole
disease MESH arc
drug DRUGBANK 3 7 11 15-Tetramethyl-Hexadecan-1-Ol

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *